PRECIGEN, INC.

Profile

Company Names

PRECIGEN, INC.
INTREXON CORP

Addresses

222 LAKEVIEW AVENUE, SUITE 1400, WEST PALM BEACH, FL 33401

20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD 20876

1750 KRAFT DRIVE, SUITE 1400, BLACKSBURG, VA 24060

1872 PRATT DRIVE, SUITE 1400, BLACKSBURG, VA 24060

Phone Numbers

301-556-9900
561-410-7000
540-961-0725

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

VIRGINIA

Total Amount Raised:

$659,033,577.00

Number of Funding Rounds:

20
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
20
2020-12-02 
$13,000,000.00 
$13,000,000.00 
$0.00 
Equity 
19
2020-01-31 
$35,000,000.00 
$35,000,000.00 
$0.00 
Equity 
18
2016-02-24 
$4,250,000.00 
$4,250,000.00 
$0.00 
Equity 
17
2015-09-04 
$21,585,401.00 
$21,585,401.00 
$0.00 
Equity 
16
2015-02-24 
$450,015.00 
$450,015.00 
$0.00 
Equity 
15
2015-02-23 
$10,196,546.00 
$10,196,546.00 
$0.00 
Equity 
14
2015-01-13 
$57,500,000.00 
$57,500,000.00 
$0.00 
Equity 
13
2014-08-08 
$28,634,166.00 
$28,634,166.00 
$0.00 
Equity 
12
2014-03-27 
$24,999,943.00 
$24,999,943.00 
$0.00 
Equity 
11
2013-03-01 
$150,000,000.00 
$150,000,000.00 
$0.00 
Equity 
10
2012-10-26 
$25,000,002.00 
$25,000,002.00 
$0.00 
Equity 
9
2011-12-23 
$75,000,006.00 
$75,000,006.00 
$0.00 
Equity 
8
2011-10-31 
$1,092,344.00 
$1,092,344.00 
$0.00 
Equity 
7
2011-08-31 
$17,000,004.00 
$17,000,004.00 
$0.00 
Equity 
6
2011-05-26 
$91,825,055.00 
$91,825,055.00 
$0.00 
Equity 
5
2011-04-18 
$550,001.00 
$550,001.00 
$0.00 
Equity 
4
2011-01-26 
$1,013,625.00 
$1,346,625.00 
$333,000.00 
Equity 
3
2010-02-19 
$66,936,470.00 
$66,936,470.00 
$0.00 
Equity 
2
2009-12-22 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
1
2009-06-16 
$9,999,999.00 
$9,999,999.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CESAR 
L. 
ALVAREZ 
DIRECTOR
INTREXON CORP   |  MEDNAX, INC.   |  PRECIGEN, INC.
ROBERT 
P. 
BEECH 
EXECUTIVE OFFICER
INTREXON CORP   |  LSI INDUSTRIES INC
JACK 
A. 
BOBO 
EXECUTIVE OFFICER
INTREXON CORP
SAMUEL 
 
BRODER 
EXECUTIVE OFFICER
INTREXON CORP   |  CATALYTIC IP INC   |  GENEOS THERAPEUTICS, INC.
SUNIL 
 
CHADA 
EXECUTIVE OFFICER
INTREXON CORP
GRACE 
 
COLON 
EXECUTIVE OFFICER
INTREXON CORP   |  INCARDA THERAPEUTICS, INC.   |  PERCEPTIMED, INC.   |  COCOON BIOTECH INC.   |  PARADIGM DIAGNOSTICS, INC.   |  VOYAGER THERAPEUTICS, INC.
GRACE 
E. 
COLON 
EXECUTIVE OFFICER
INTREXON CORP
ENA 
CHAN 
CRATSENBURG 
EXECUTIVE OFFICER
INTREXON CORP
MATT 
 
CRISP 
EXECUTIVE OFFICER
INTREXON CORP   |  VIKARTA INC   |  ALWAYSONVACATION, INC.   |  SPORTSCALE, INC.
MATTHEW 
B. 
CRISP 
EXECUTIVE OFFICER
CYNTELLECT INC   |  CYNTELLECT, INC   |  INTREXON CORP   |  ICHOR MICROBIAL SOLUTIONS, INC.
STEVEN 
 
FRANK 
DIRECTOR
INTREXON CORP   |  SAGE AUTOMOTIVE INTERIORS, INC.   |  C4 IMAGING, LLC   |  PRECIGEN, INC.
STEVEN 
J. 
FRANK 
DIRECTOR
PANEVE LLC   |  INTREXON CORP   |  C4 IMAGING, LLC
GREGORY 
I. 
FROST 
EXECUTIVE OFFICER
INTREXON CORP
TOM 
 
GORALSKI 
EXECUTIVE OFFICER
INTREXON CORP
VINITA 
D. 
GUPTA 
DIRECTOR
PRECIGEN, INC.
FRED 
 
HASSAN 
DIRECTOR
MODERNIZING MEDICINE, INC.   |  PRECIGEN, INC.
RONALD 
B. 
HERBERMAN 
EXECUTIVE OFFICER
CELSENSE INC   |  INTREXON CORP
LARRY 
 
HORNER 
DIRECTOR
INTREXON CORP
LARRY 
D. 
HORNER 
DIRECTOR
INTREXON CORP
KELLY 
 
HUANG 
EXECUTIVE OFFICER
INTREXON CORP   |  ELUCID BIOIMAGING INC.
COREY 
 
HUCK 
EXECUTIVE OFFICER
INTREXON CORP   |  PROVIVI, INC.
OLIVIER 
R. 
JARRY 
EXECUTIVE OFFICER
INTREXON CORP   |  OS THERAPIES INC
TIMOTHY 
 
KASBE 
EXECUTIVE OFFICER
INTREXON CORP
TIMOTHY 
D. 
KASBE 
EXECUTIVE OFFICER
INTREXON CORP
THOMAS 
 
KASSER 
EXECUTIVE OFFICER
INTREXON CORP
THOMAS 
R. 
KASSER 
EXECUTIVE OFFICER
INTREXON CORP   |  AQUABOUNTY TECHNOLOGIES, INC.
JEFFREY 
 
KINDLER 
DIRECTOR
INTREXON CORP   |  JAGUAR HOLDING CO I   |  GBS HOLDINGS, LLC   |  VTV THERAPEUTICS INC.   |  TERNS PHARMACEUTICALS, INC.
JEFFREY 
B. 
KINDLER 
DIRECTOR
INTREXON CORP   |  CENTREXION CORP   |  CENTREXION THERAPEUTICS CORP   |  PRECIGEN, INC.
JEFFREY 
L. 
KINDLER 
DIRECTOR
INTREXON CORP
RANDAL 
 
KIRK 
DIRECTOR, EXECUTIVE OFFICER
ZIOPHARM ONCOLOGY INC   |  PRECIGEN, INC.
RANDAL 
J. 
KIRK 
EXECUTIVE OFFICER, DIRECTOR
INTREXON CORP   |  CYNTELLECT INC   |  CYNTELLECT, INC   |  PINNACLE PHARMACEUTICALS INC   |  VALLEYS- VENTURES, LP   |  ZIOPHARM ONCOLOGY INC   |  PRECIGEN, INC.
KRISH 
S. 
KRISHNAN 
EXECUTIVE OFFICER
PINNACLE PHARMACEUTICALS INC   |  INTREXON CORP   |  KRYSTAL BIOTECH, INC.
SUMA 
M. 
KRISHNAN 
EXECUTIVE OFFICER
PINNACLE PHARMACEUTICALS INC   |  INTREXON CORP   |  KRYSTAL BIOTECH, INC.
DONALD 
 
LEHR 
EXECUTIVE OFFICER
INTREXON CORP
DONALD 
P. 
LEHR 
EXECUTIVE OFFICER
INTREXON CORP   |  PRECIGEN, INC.
JOEL 
D. 
LIFFMAN 
EXECUTIVE OFFICER
INTREXON CORP
JOEL 
D. 
LIFFMANN 
EXECUTIVE OFFICER
PHARMACA INTEGRATIVE PHARMACY INC   |  INHEALTH HOLDINGS, LLC   |  INTREXON CORP
NICK 
 
MACRIS 
EXECUTIVE OFFICER
INTREXON CORP
DEAN 
J. 
MITCHELL 
DIRECTOR
INTREXON CORP   |  PRECIGEN, INC.
GLENN 
 
NEDWIN 
EXECUTIVE OFFICER
INTREXON CORP   |  PRONUTRIA BIOSCIENCES, INC.
NIR 
 
NIMRODI 
EXECUTIVE OFFICER
INTREXON CORP   |  LEUKODX, INC.   |  EVOGENE LTD.
JEFFREY 
 
PEREZ 
EXECUTIVE OFFICER
PRECIGEN, INC.
JEFFREY 
T. 
PEREZ 
EXECUTIVE OFFICER
INTREXON CORP
MARCELO 
 
QUIROGA 
EXECUTIVE OFFICER
INTREXON CORP
THOMAS 
 
REED 
EXECUTIVE OFFICER, DIRECTOR
INTREXON CORP   |  FORT DEARBORN HOLDING COMPANY, INC.   |  ALTAVIAN INC.   |  IMA FINANCIAL GROUP, INC.   |  BIOSOLUTION DESIGNS, INC.
THOMAS 
D. 
REED 
EXECUTIVE OFFICER, DIRECTOR
INTREXON CORP
THOMAS 
 
REED, PH.D. 
EXECUTIVE OFFICER
PRECIGEN, INC.
JAYSON 
 
RIEGER 
EXECUTIVE OFFICER
INTREXON CORP   |  VERRICA PHARMACEUTICALS INC.   |  XALUD THERAPEUTICS, INC.
JAYSON 
M. 
RIEGER 
EXECUTIVE OFFICER
INTREXON CORP
HELEN 
 
SABZEVARI, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
PRECIGEN, INC.
ROBERT 
 
SHAPIRO 
DIRECTOR
SHOEDAZZLE.COM INC   |  THERANOS INC   |  AGRAQUEST INC   |  ELEVANCE RENEWABLE SCIENCES, INC.   |  PATHFINDER RAINTREE RESIDENTIAL II, L.P.   |  WOODBRIDGE PRE-SETTLEMENT FUNDING, LLC   |  INTREXON CORP   |  WOODBRIDGE PRE-SETTLEMENT FUNDING 2, LLC   |  CULTIVIAN SANDBOX FOOD + AGRICULTURE FUND II, LP   |  CHROMATIN, INC.   |  HEALTHBOX NASHVILLE I LLC   |  HEALTHBOX GLOBAL PARTNERS, LLC   |  HEALTHBOX CHICAGO II LLC   |  HEALTHBOX CHICAGO III LLC   |  HEALTHBOX SALT LAKE CITY I, LLC   |  CONSERVIS CORP.   |  WOODBRIDGE MORTGAGE INVESTMENT FUND 3, LLC   |  WOODBRIDGE COMMERCIAL BRIDGE LOAN FUND 1, LLC   |  GETTRAINED, INC.   |  CANTIUM HOLDCO, LLC   |  CULTIVIAN SANDBOX FOOD + AGRICULTURE FUND III, LP   |  INFLECTION MERCURY FUND, LP   |  AMERICO BANCSHARES, INC.
ROBERT 
B. 
SHAPIRO 
DIRECTOR
INTREXON CORP   |  PRECIGEN, INC.
BURTON 
 
SOBEL 
DIRECTOR
INTREXON CORP
RICK 
 
STERLING 
EXECUTIVE OFFICER
INTREXON CORP   |  AQUABOUNTY TECHNOLOGIES, INC.   |  WSO HOLDINGS, LP   |  AQUABOUNTY TECHNOLOGIES INC
RICK 
L. 
STERLING 
EXECUTIVE OFFICER
INTREXON CORP   |  PRECIGEN, INC.
JAMES 
S. 
TURLEY 
DIRECTOR
INTREXON CORP   |  PRECIGEN, INC.
JOSEPH 
L. 
VAILLANCOURT 
EXECUTIVE OFFICER
INTREXON CORP
ROBERT 
F. 
WALSH, III 
EXECUTIVE OFFICER
INTREXON CORP
DARRYL 
 
WEBSTER 
EXECUTIVE OFFICER
INTREXON CORP
DAVID 
J. 
ZACCARDI 
DIRECTOR
INTREXON CORP
GERARDO 
 
ZAPATA 
EXECUTIVE OFFICER
INTREXON CORP
GERARDO 
A. 
ZAPATA 
EXECUTIVE OFFICER
INTREXON CORP
SAIID 
 
ZARRABIAN 
EXECUTIVE OFFICER
AMBIT BIOSCIENCES CORP   |  CYNTELLECT, INC   |  INTREXON CORP   |  LA JOLLA PHARMACEUTICAL CO   |  KINTARA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-12-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Equity 
2020-12-02 
2020-02-11
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
OVER $100,000,000 
Equity 
2020-01-31 
2016-03-09
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$25,000,001 - $100,000,000 
Equity 
2016-02-24 
2015-09-21
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$25,000,001 - $100,000,000 
Equity 
2015-09-04 
2015-03-11
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$25,000,001 - $100,000,000 
Equity 
2015-02-24 
2015-03-09
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$25,000,001 - $100,000,000 
Equity 
2015-02-23 
2015-01-28
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$5,000,001 - $25,000,000 
Equity 
2015-01-13 
2014-08-22
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$5,000,001 - $25,000,000 
Equity 
2014-08-08 
2014-04-10
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$5,000,001 - $25,000,000 
Equity 
2014-03-27 
2013-05-15
D/A
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2013-03-01 
2013-03-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-01 
2012-11-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-26 
2012-04-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-23 
2012-01-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-23 
2012-01-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-23 
2011-11-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-10-31 
2011-09-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-31 
2011-06-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-26 
2011-05-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-18 
2011-04-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-19 
2011-02-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-19 
2011-02-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-26 
2010-11-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-19 
2010-03-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-19 
2010-01-05
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-12-22 
2009-06-29
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-06-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
BARCLAYS CAPITAL INC.
19714
NONE
NONE
GRIFFIN SECURITIES, INC.
43229
NONE
NONE
PERELLA WEINBERG PARTNERS LP
138618